4.7 Article

Fetuin-A: A Novel Biomarker of Bone Damage in Early Axial Spondyloarthritis. Results of an Interim Analysis of the SPACE Study

Related references

Note: Only part of the references are listed.
Article Rheumatology

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Sofia Ramiro et al.

Summary: The ASAS-EULAR recommendations provide updated guidance on the management of axial spondyloarthritis, including treatment targets, non-pharmacological interventions, and the use of non-steroidal anti-inflammatory drugs (NSAIDs) as the first-line pharmacological treatment. For patients with comorbidities, the use of biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) is recommended. The recommendations also cover the management of extramusculoskeletal manifestations, tapering of bDMARDs, and surgical interventions.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Axial spondyloarthritis and inflammatory bowel disease: association between disease activity and endothelial dysfunction markers

Hanna Przepiera-Bedzak et al.

Summary: Patients with axSpA and IBD had higher disease activity levels, as indicated by ESR and CRP levels and ET-1 levels, compared to those with axSpA without IBD. Patients with axSpA and IBD also exhibited increased IL-18 and ADMA levels, and decreased fetuin-A levels compared to healthy controls.

RHEUMATOLOGY INTERNATIONAL (2022)

Review Cell Biology

The structure, biosynthesis, and biological roles of fetuin-A: A review

Endeshaw Chekol Abebe et al.

Summary: Fetuin-A is a plasma glycoprotein with diverse physiological and pathological functions, involved in calcium metabolism, osteogenesis, and insulin signaling pathway. It also functions as a calcification inhibitor, protease inhibitor, and inflammatory regulator, and plays a crucial role in the pathogenesis of various disorders.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Letter Immunology

Do we believe in non-radiographic axial spondyloarthritis? A debate

Augusta Ortolan et al.

AUTOIMMUNITY REVIEWS (2021)

Article Medical Laboratory Technology

Emerging role of monocytes and their intracellular calcium pattern in spondyloarthritis

Stefania Moz et al.

CLINICA CHIMICA ACTA (2020)

Article Clinical Neurology

Reduced plasma Fetuin-A is a promising biomarker of depression in the elderly

Giuseppe Fanelli et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)

Review Rheumatology

An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision

Mariagrazia Lorenzin et al.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2020)

Article Rheumatology

Treat to Target in Axial Spondyloarthritis

Elena Nikiphorou et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2019)

Article Medicine, General & Internal

Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)

Mariagrazia Lorenzin et al.

FRONTIERS IN MEDICINE (2019)

Review Medicine, General & Internal

The Role of Imaging in Diagnosing Axial Spondyloarthritis

Nikita Khmelinskii et al.

FRONTIERS IN MEDICINE (2018)

Article Cardiac & Cardiovascular Systems

Could circulating fetuin A be a biomarker of aortic valve stenosis?

Alessandro Di Minno et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Review Biochemistry & Molecular Biology

Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors

Stefania Moz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Medicine, General & Internal

Axial spondyloarthritis

Joachim Sieper et al.

LANCET (2017)

Review Immunology

An update on biomarkers in axial spondyloarthritis

Klara Prajzlerova et al.

AUTOIMMUNITY REVIEWS (2016)

Article Biochemistry & Molecular Biology

Levels of serum pentraxin 3, IL-6, fetuin A and insulin in patients with rheumatoid arthritis

Ibrahim Tekeoglu et al.

CYTOKINE (2016)

Article Health Care Sciences & Services

Clinimetric properties of the ASAS health index in a cohort of Italian patients with axial spondyloarthritis

Marco Di Carlo et al.

HEALTH AND QUALITY OF LIFE OUTCOMES (2016)

Article Biochemistry & Molecular Biology

Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome

Hanna Przepiera-Bedzak et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Article Orthopedics

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Mariagrazia Lorenzin et al.

BMC MUSCULOSKELETAL DISORDERS (2015)

Article Rheumatology

Bone formation in axial spondyloarthritis

Rik J. Lories et al.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2014)

Article Medicine, General & Internal

Serum fetuin-A levels in postmenopausal women with osteoporosis

Esin Ozkan et al.

TURKISH JOURNAL OF MEDICAL SCIENCES (2014)

Review Cardiac & Cardiovascular Systems

Fetuin-A Regulation of Calcified Matrix Metabolism

Willi Jahnen-Dechent et al.

CIRCULATION RESEARCH (2011)

Article Pharmacology & Pharmacy

Fetuin-A: A Multifunctional Protein

Katsuhito Mori et al.

RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2011)

Article Rheumatology

Fetuin-A and interleukin-18 levels in ankylosing spondylitis

Ismail Sari et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2010)

Article Rheumatology

Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system

MCW Creemers et al.

ANNALS OF THE RHEUMATIC DISEASES (2005)